Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shi

Showing results (1391-1400 of 1,428) with videos related to

Pageof 143
Sort By:
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Communications Biology|November 21, 2023
Single-cell and spatial architecture of primary liver cancerPei-Yun Zhou, Cheng Zhou, Wei Gan, et al.
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
Plos One|November 3, 2018
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironmentsJong W Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 24, 2014
8q24 rs4242382 polymorphism is a risk factor for prostate cancer among multi-ethnic populations: evidence from clinical detection in China and a meta-analysisCheng-Xiao Zhao, Ming Liu, Yong Xu, et al.
Journal of Medicinal Chemistry|January 25, 2021
Bicyclic Ligand-Biased Agonists of S1P<sub>1</sub>: Exploring Side Chain Modifications to Modulate the PK, PD, and Safety ProfilesJohn L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Plos One|March 12, 2014
A linguistically informed autosomal STR survey of human populations residing in the greater Himalayan regionThirsa Kraaijenbrink, Kristiaan J van der Gaag, Sofia B Zuniga, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Hepatology (Baltimore, Md.)|January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progressionJia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Frontiers in Immunology|July 18, 2022
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective StudyQian-Qian Liao, Ya-Fei Ren, Ke-Wei Zhu, et al.
Pageof 143

Showing results (1391-1400 of 1,428) with videos related to

Sort By:
Pageof 143
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Communications Biology|November 21, 2023
Single-cell and spatial architecture of primary liver cancerPei-Yun Zhou, Cheng Zhou, Wei Gan, et al.
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
Plos One|November 3, 2018
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironmentsJong W Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 24, 2014
8q24 rs4242382 polymorphism is a risk factor for prostate cancer among multi-ethnic populations: evidence from clinical detection in China and a meta-analysisCheng-Xiao Zhao, Ming Liu, Yong Xu, et al.
Journal of Medicinal Chemistry|January 25, 2021
Bicyclic Ligand-Biased Agonists of S1P<sub>1</sub>: Exploring Side Chain Modifications to Modulate the PK, PD, and Safety ProfilesJohn L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Plos One|March 12, 2014
A linguistically informed autosomal STR survey of human populations residing in the greater Himalayan regionThirsa Kraaijenbrink, Kristiaan J van der Gaag, Sofia B Zuniga, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Hepatology (Baltimore, Md.)|January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progressionJia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Frontiers in Immunology|July 18, 2022
Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective StudyQian-Qian Liao, Ya-Fei Ren, Ke-Wei Zhu, et al.
Pageof 143